SCHEMBL8762158

SCHEMBL8762158

Cc1c([N+](=O)[O-])ccc(Br)c1Br

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.55
TDP1 Q9NUW8 1/20 0.54
TSHR P16473 6/20 0.48
SMN1; SMN2 Q16637 3/20 0.48
CYP3A4 P08684 2/20 0.45
ALDH1A1 P00352 4/20 0.42
CYP2D6 P10635 1/20 0.42
HSD17B10 Q99714 1/20 0.42
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
MAPT P10636 2/20 0.40
CYP2C19 P33261 1/20 0.40
KDM4E B2RXH2 1/20 0.40
LMNA P02545 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
BCHE P06276 1/20 0.39
ACHE P22303 1/20 0.39
CES1 P23141 1/20 0.39
HPGD P15428 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29727839 0.85 TDP1 (0.56) CYP1A2TDP1TSHRSMN1; SMN2CYP3A4
SCHEMBL27683829 0.85 TDP1 (0.56) CYP1A2TDP1TSHRSMN1; SMN2CYP3A4
SCHEMBL9575258 0.83 CYP1A2 (0.50) CYP1A2TDP1TSHRSMN1; SMN2CYP3A4
SCHEMBL61678 0.83 CYP1A2 (0.60) CYP1A2TDP1TSHRSMN1; SMN2CYP3A4
SCHEMBL11394486 0.82 TDP1 (0.52) CYP1A2TDP1TSHRSMN1; SMN2CYP3A4
SCHEMBL11034572 0.80 TDP1 (0.50) CYP1A2TDP1TSHRSMN1; SMN2CYP3A4
SCHEMBL1993159 0.80 CYP1A2 (0.52) CYP1A2TDP1TSHRSMN1; SMN2CYP3A4
SCHEMBL22833410 0.80 CYP1A2 (0.52) CYP1A2TDP1TSHRSMN1; SMN2CYP3A4
SCHEMBL29507015 0.80 CYP1A2 (0.52) CYP1A2TDP1TSHRSMN1; SMN2CYP3A4
SCHEMBL26133898 0.80 TDP1 (0.50) CYP1A2TDP1TSHRSMN1; SMN2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5698580-A TREATING DISEASES CAUSED BY RESPIRATORY SYNCYTIAL VIRUS RATIONAL DRUG DESIGN LABORATORIES (JP) 1997-12-16 US disclosed
EP-0770609-A1 ANTIVIRAL AGENT CONTAINING BENZODITHIIN DERIVATIVE AS ACTIVE INGREDIENT Rational Drug Design Laboratories (JP) 1997-05-02 EP disclosed